Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 984 publications

High-fidelity prediction of drug solubility in supercritical CO₂ for pharmaceutical applications using advanced computational modeling.

High-fidelity prediction of drug solubility in supercritical CO₂ for pharmaceutical applications using advanced computational modeling.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: September 10, 2025

Neurologic Medication Costs in a Direct-to-Consumer Pharmacy vs Commercial Insurance Plans.

Neurologic Medication Costs in a Direct-to-Consumer Pharmacy vs Commercial Insurance Plans.

Journal: JAMA network open
Published: August 19, 2025

Comprehensive Identification and Mechanistic Evaluation of Novel DHODH Inhibitors as Potent Broad-Spectrum Antiviral Agents.

Comprehensive Identification and Mechanistic Evaluation of Novel DHODH Inhibitors as Potent Broad-Spectrum Antiviral Agents.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 08, 2025

Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis.

Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis.

Journal: Neurology
Published: July 30, 2025

Characterizing post-COVID-19 syndrome in multiple sclerosis: Vaccine status, infection burden, and therapy categories as predictors.

Characterizing post-COVID-19 syndrome in multiple sclerosis: Vaccine status, infection burden, and therapy categories as predictors.

Journal: Multiple sclerosis and related disorders
Published: July 29, 2025

Efficacy and safety of ublituximab for relapsing multiple sclerosis patients: current evidence and expert opinion.

Efficacy and safety of ublituximab for relapsing multiple sclerosis patients: current evidence and expert opinion.

Journal: Journal of neurology
Published: July 28, 2025

Teriflunomide treatment for relapsing-remitting multiple sclerosis: An experience from Saudi Arabia.

Teriflunomide treatment for relapsing-remitting multiple sclerosis: An experience from Saudi Arabia.

Journal: Medicine
Published: July 24, 2025

Case Report: Papillary Dermal Elastolysis in a Patient Receiving Teriflunomide Therapy.

Case Report: Papillary Dermal Elastolysis in a Patient Receiving Teriflunomide Therapy.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: July 01, 2025

Prevalence of hypogammaglobulinemia after non-anti-CD20 therapies and impact of switching to rituximab/ocrelizumab in multiple sclerosis.

Prevalence of hypogammaglobulinemia after non-anti-CD20 therapies and impact of switching to rituximab/ocrelizumab in multiple sclerosis.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: June 19, 2025

Beyond Efficacy: Persistence, NEDA, and Therapeutic Decision-Making in First-Line Multiple Sclerosis Treatment.

Beyond Efficacy: Persistence, NEDA, and Therapeutic Decision-Making in First-Line Multiple Sclerosis Treatment.

Journal: Neurology and therapy
Published: June 17, 2025

Breaking the assumption: Disease-modifying therapy efficacy and relapse severity in relapsing-remitting multiple sclerosis.

Breaking the assumption: Disease-modifying therapy efficacy and relapse severity in relapsing-remitting multiple sclerosis.

Journal: Multiple sclerosis and related disorders
Published: June 05, 2025

Optimizing treatment for pediatric multiple sclerosis.

Optimizing treatment for pediatric multiple sclerosis.

Journal: Expert review of neurotherapeutics
Published: May 30, 2025
Showing 1-12 of 984

Last Updated: 10/31/2025